Sabril and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Sabril (vigabatrin), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Lamictal, and have Epilepsy.

The phase IV clinical study analyzes which people have Joint pain when taking Sabril. It is created by eHealthMe based on reports of 12,433 people who have side effects when taking Sabril from the FDA, and is updated regularly.

What is Sabril?

Sabril has active ingredients of vigabatrin. eHealthMe is studying from 12,445 Sabril users. Check the latest studies of Sabril.

What is Joint pain?

Joint pain is found to be associated with 3,331 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 20, 2026

12,433 people reported to have side effects when taking Sabril.
Among them, 30 people (0.24%) have Joint pain.

Among these 30 people:

How long have people been on Sabril when they have Joint pain? *

What is the gender of people who have Joint pain when taking Sabril? *

female: 76.67 %
male: 23.33 %

What is the age of people who have Joint pain when taking Sabril? *

What are other drugs people take besides Sabril? *

What are other side effects people have besides Joint pain? *

Dizziness: 11 people, 36.67%
Pain In Extremity: 10 people, 33.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 23.33%
Fatigue (feeling of tiredness): 7 people, 23.33%
Confusion: 7 people, 23.33%
Rashes (redness): 7 people, 23.33%
Feeling Abnormal: 7 people, 23.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 20.00%
Weakness: 6 people, 20.00%
Feeling Hot: 6 people, 20.00%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 36.67%
Complex Partial Seizures (epileptic seizure): 9 people, 30.00%
Temporal Lobe Epilepsy (a term that refers to a condition where seizures are generated in the portion of the brain called the temporal lobe): 6 people, 20.00%
Tuberous Sclerosis (a rare genetic disease that causes benign tumours to grow in the brain and other organs): 5 people, 16.67%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 13.33%
Astrocytoma, Low Grade (low grade tumour of the brain that originate in a particular kind of glial-cells): 2 people, 6.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 3.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.33%
High Blood Cholesterol: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sabril and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sabril:

Sabril (12,445 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Sabril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,331 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vigabatrin (the active ingredients of Sabril) and Sabril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.